|
시장보고서
상품코드
2075220
렙토스피라증 시장 : 약제별, 진단별, 투여 경로별, 유통 채널별 및 지역별Leptospirosis Market, by Drug, by Diagnosis, by Route of Administration, by Distribution Channel, and by Region |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
렙토스피라증 시장은 2026년에 5억 8,970만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 8억 8,670만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 6.0%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 5억 8,970만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 6.00% | 2033년 시장 규모 예측 : | 8억 8,670만 달러 |
렙토스피라증의 원인이 되는 세균은 레프토스피라라고 불립니다. 렙토스피라증은 사람과 동물에게 전염되는 질병입니다. 감염되면 다양한 증상이 나타날 수 있지만, 그중에는 다른 질환의 증상으로 오인될 수 있는 것도 있습니다. 렙토스피라증의 대부분은 열대 지역에서 발생하고 있습니다. 미국에서는 매년 100-150건의 인간 감염 사례가 보고되는 경우가 흔합니다. 야외에서 일하시는 분, 동물 근처에서 일하시는 분, 혹은 담수에서 활동하시는 분은 감염될 위험이 높을 수 있습니다. 렙토스피라증에 감염되면 심각한 증상이 나타날 수도 있고, 전혀 증상이 나타나지 않을 수도 있습니다. 렙토스피라증으로 인해 급격한 발열, 오한, 두통, 심한 전신 통증, 권태감 등의 독감 유사 증상이 나타날 수 있습니다. 환자의 10%에서는 간, 신장 또는 신경계에 영향을 미치는 더 심각한 병세가 발생할 가능성이 있습니다. 렙토스피라증은 의사가 특정 항생제를 처방하면 치료할 수 있습니다. 이 병에 걸린 분은 가능한 한 빨리 치료를 받아야 합니다.
시장 역학
연구 기관들이 렙토스피라증 치료를 목적으로 한 백신 개발에 주력하는 연구개발 활동이 증가함에 따라 예측 기간 중 전 세계 렙토스피라증 시장의 성장을 촉진할 것으로 예상됩니다. 예를 들어 2022년 7월 6일, 미국 예일대 의과대학은 치명적인 렙토스피라균을 대상으로 한 백신 개발에 주력하고 있다고 발표했습니다. 다음 단계는 실험실에서 얻은 발견을 백신 개발에 적용하는 것이며, 우선 동물용 백신으로 시작해 이후 인간용 백신으로 확대해 나갈 예정입니다.
본 조사의 주요 특징 :
- 이 조사에서는 다양한 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 렙토스피라증 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 이 세계의 렙토스피라증 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 렙토스피라증 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 렙토스피라증 시장 : 약물별, 2021-2033년
제5장 세계의 렙토스피라증 시장 : 진단별, 2021-2033년
제6장 세계의 렙토스피라증 시장 : 투여 경로별, 2021-2033년
제7장 세계의 렙토스피라증 시장 : 유통 채널별, 2021-2033년
제8장 세계의 렙토스피라증 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 섹션
KSA 26.07.07Leptospirosis Market is estimated to be valued at USD 589.7 Mn in 2026 and is expected to reach USD 886.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 589.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.00% | 2033 Value Projection: | USD 886.7 Mn |
The bacterium that causes Leptospirosis is called leptospira. Leptospirosis is a disease that can affect humans and animals. People may experience a variety of symptoms from it, some of which may be mistaken for those of other disorders. Most cases of leptospirosis occur in tropical regions. In the U.S., 100 to 150 cases of human sickness are often documented each year. People who work outside, around animals, or who engage in freshwater activities could be more susceptible to infection. Leptospirosis exposure can cause severe symptoms or sometimes no symptoms at all in a person. Flu-like symptoms, including rapid fever, chills, headache, excruciating body aches, and weariness, can be brought on by leptospirosis. A more serious sickness affecting the liver, kidneys, or neurological system may happen in 10% of patients. Leptospirosis can be treated by a doctor prescribing particular antibiotics. Those who have this disease must get treated as soon as possible.
Market Dynamics
Increasing research and development activities focused on vaccine development for the treatment of leptospirosis by research institutes are expected to drive the global leptospirosis market's growth over the forecast period. For instance, on July 6, 2022, The Yale School of Medicine, U.S., announced the university is focused on the vaccine development indicated for the deadly Leptospirosis bacteria. The next step is to translate the laboratory discovery into vaccines, first for animals and then for humans.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global leptospirosis market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include USAntibiotics, Dr. Reddy's Laboratories Ltd., Century Pharmaceuticals Ltd., Mayne Pharma Group Limited, Sun Pharmaceutical Industries, Inc., Ralington Pharma, F. Hoffmann-La Roche Ltd, Pfizer Inc., Sandoz International GmbH, ISKON REMEDIES & GMT, Haustus Biotech Pvt. Ltd., and Aden Healthcare
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global leptospirosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leptospirosis market
Detailed Segmentation:
- Global Leptospirosis Market, By Drug (Revenue, USD Mn, 2021 - 2033)
- Amoxicillin
- Azithromycin
- Cefixime
- Doxycycline
- Others (Ceftriaxone,Penicillin among others)
- Global Leptospirosis Market, By Diagnosis (Revenue, USD Mn, 2021 - 2033)
- Complete Blood Count (CBC)
- Creatine Kinase
- Liver Enzymes
- Urinalysis
- Others (Lumbar puncture, Microscopic agglutination test among others)
- Global Leptospirosis Market, By Route of Administration (Revenue, USD Mn, 2021 - 2033)
- Oral
- Parenteral
- Intravenous
- Global Leptospirosis Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Leptospirosis Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- USAntibiotics
- Reddy's Laboratories Ltd.
- Century Pharmaceuticals Ltd.
- Mayne Pharma Group Limited
- Sun Pharmaceutical Industries, Inc.
- Ralington Pharma,
- F.Hoffmann-La Roche Ltd
- Pfizer Inc.
- Sandoz International GmbH
- ISKON REMEDIES & GMT
- Haustus Biotech Pvt. Ltd.
- Aden Healthcare
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug
- Market Snapshot, By Diagnosis
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Regulatory Guidelines
- Product launches
- Key Development
- PEST Analysis
- Regulatory Scenario
- Mergers and Acquisitions
4. Global Leptospirosis Market, By Drug, 2021 - 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Amoxicillin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Azithromycin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Cefixime
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Doxycycline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Others (Ceftriaxone, Penicillin among others)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
5. Global Leptospirosis Market, By Diagnosis, 2021 - 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Complete Blood Count (CBC)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Creatine Kinase
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Liver Enzymes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Urinalysis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Others (Lumbar puncture, Microscopic agglutination test among others)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
6. Global Leptospirosis Market, By Route of Administration, 2021 - 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Intravenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
7. Global Leptospirosis Market, By Distribution Channel, 2021 - 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
8. Global Leptospirosis Market, By Region, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Regions, 2021 - 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- USAntibiotics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Reddy's Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Century Pharmaceuticals Ltd.
- Company Highlight
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mayne Pharma Group Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sun Pharmaceutical Industries, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ralington Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sandoz International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ISKON REMEDIES & GMT
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Haustus Biotech Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aden Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
